Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Nuclear Physics | 6 | 2014 | 79 | 0.690 |
Why?
|
Elementary Particles | 4 | 2014 | 55 | 0.460 |
Why?
|
Myeloproliferative Disorders | 4 | 2015 | 606 | 0.450 |
Why?
|
Chromosome Aberrations | 4 | 2013 | 1811 | 0.420 |
Why?
|
Oxidoreductases Acting on CH-CH Group Donors | 2 | 2023 | 167 | 0.400 |
Why?
|
Hormone Replacement Therapy | 1 | 2016 | 708 | 0.380 |
Why?
|
Decidua | 1 | 2011 | 86 | 0.370 |
Why?
|
Abortion, Habitual | 1 | 2011 | 70 | 0.370 |
Why?
|
Cesarean Section, Repeat | 1 | 2009 | 29 | 0.340 |
Why?
|
Calreticulin | 3 | 2014 | 98 | 0.330 |
Why?
|
Receptors, Progesterone | 1 | 2013 | 1098 | 0.330 |
Why?
|
Arsenic | 1 | 2012 | 328 | 0.330 |
Why?
|
Thrombocythemia, Essential | 3 | 2014 | 105 | 0.320 |
Why?
|
Water Pollutants, Chemical | 1 | 2012 | 311 | 0.320 |
Why?
|
Models, Theoretical | 6 | 2014 | 3587 | 0.290 |
Why?
|
Receptors, Estrogen | 2 | 2022 | 2190 | 0.290 |
Why?
|
Adenocarcinoma, Mucinous | 1 | 2011 | 507 | 0.290 |
Why?
|
Placenta Diseases | 1 | 2009 | 199 | 0.280 |
Why?
|
Leukemia, Myeloid, Acute | 4 | 2022 | 3524 | 0.280 |
Why?
|
Neuroblastoma | 4 | 2022 | 1226 | 0.270 |
Why?
|
Primary Myelofibrosis | 4 | 2014 | 215 | 0.250 |
Why?
|
Neoplasms, Second Primary | 1 | 2012 | 1063 | 0.240 |
Why?
|
Hypereosinophilic Syndrome | 2 | 2015 | 93 | 0.230 |
Why?
|
Receptor, erbB-2 | 1 | 2013 | 2418 | 0.230 |
Why?
|
Elementary Particle Interactions | 2 | 2013 | 19 | 0.230 |
Why?
|
Janus Kinase 2 | 4 | 2014 | 528 | 0.230 |
Why?
|
Barth Syndrome | 1 | 2022 | 25 | 0.210 |
Why?
|
Killer Cells, Natural | 1 | 2011 | 2131 | 0.200 |
Why?
|
Epigenesis, Genetic | 2 | 2022 | 3645 | 0.190 |
Why?
|
Registries | 2 | 2017 | 8090 | 0.190 |
Why?
|
Acyltransferases | 1 | 2022 | 294 | 0.180 |
Why?
|
Neutrophils | 2 | 2023 | 3718 | 0.180 |
Why?
|
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2023 | 407 | 0.170 |
Why?
|
Candidiasis | 1 | 2022 | 366 | 0.170 |
Why?
|
Toll-Like Receptors | 1 | 2022 | 593 | 0.160 |
Why?
|
Receptors, Thrombopoietin | 3 | 2013 | 157 | 0.150 |
Why?
|
Mesons | 2 | 2014 | 33 | 0.140 |
Why?
|
Neutropenia | 1 | 2022 | 895 | 0.140 |
Why?
|
Myositis Ossificans | 1 | 2017 | 79 | 0.140 |
Why?
|
Leukemia | 2 | 2022 | 1509 | 0.140 |
Why?
|
Oncogene Proteins, Fusion | 2 | 2015 | 1581 | 0.140 |
Why?
|
Oncogenes | 1 | 2022 | 1265 | 0.140 |
Why?
|
Proto-Oncogene Proteins c-cbl | 2 | 2013 | 119 | 0.130 |
Why?
|
DNA Modification Methylases | 1 | 2015 | 206 | 0.130 |
Why?
|
Ossification, Heterotopic | 1 | 2017 | 239 | 0.120 |
Why?
|
Cell Transformation, Neoplastic | 3 | 2013 | 2942 | 0.120 |
Why?
|
Neutrons | 1 | 2014 | 76 | 0.120 |
Why?
|
Pyrazoles | 2 | 2015 | 1970 | 0.120 |
Why?
|
Ovarian Neoplasms | 1 | 2011 | 4839 | 0.120 |
Why?
|
DNA Repair Enzymes | 1 | 2015 | 349 | 0.120 |
Why?
|
Proteins | 2 | 2023 | 6098 | 0.110 |
Why?
|
Tumor Suppressor Proteins | 2 | 2015 | 2850 | 0.110 |
Why?
|
Genome | 1 | 2022 | 1806 | 0.110 |
Why?
|
Uniparental Disomy | 1 | 2012 | 43 | 0.110 |
Why?
|
Serbia | 1 | 2012 | 15 | 0.110 |
Why?
|
Adaptor Proteins, Signal Transducing | 2 | 2013 | 2916 | 0.110 |
Why?
|
Chromosomes, Human, Pair 11 | 1 | 2013 | 417 | 0.110 |
Why?
|
Ultrasonography, Prenatal | 2 | 2010 | 1695 | 0.100 |
Why?
|
Dioxygenases | 1 | 2012 | 314 | 0.090 |
Why?
|
Proto-Oncogene Proteins | 2 | 2013 | 4552 | 0.090 |
Why?
|
Multicystic Dysplastic Kidney | 1 | 2010 | 7 | 0.090 |
Why?
|
Chromosomes, Human, Pair 6 | 1 | 2011 | 380 | 0.090 |
Why?
|
Water Supply | 1 | 2012 | 214 | 0.090 |
Why?
|
Karyotyping | 1 | 2012 | 1243 | 0.090 |
Why?
|
beta-Thalassemia | 1 | 2012 | 225 | 0.090 |
Why?
|
Loss of Heterozygosity | 1 | 2012 | 684 | 0.090 |
Why?
|
Umbilical Arteries | 1 | 2010 | 75 | 0.090 |
Why?
|
Aromatase Inhibitors | 1 | 2013 | 487 | 0.090 |
Why?
|
Kell Blood-Group System | 1 | 2009 | 22 | 0.090 |
Why?
|
High-Throughput Nucleotide Sequencing | 1 | 2022 | 3591 | 0.090 |
Why?
|
Erythroblastosis, Fetal | 1 | 2009 | 60 | 0.080 |
Why?
|
Mutation | 4 | 2014 | 29777 | 0.080 |
Why?
|
Cytomegalovirus | 1 | 2013 | 733 | 0.080 |
Why?
|
Gene Expression Regulation, Neoplastic | 2 | 2015 | 8430 | 0.080 |
Why?
|
Blood Group Incompatibility | 1 | 2009 | 146 | 0.080 |
Why?
|
Menopause | 1 | 2016 | 1626 | 0.080 |
Why?
|
Diagnostic Imaging | 1 | 2022 | 3503 | 0.080 |
Why?
|
Cell Cycle | 2 | 2013 | 2963 | 0.080 |
Why?
|
RNA Splicing | 1 | 2012 | 907 | 0.080 |
Why?
|
Abruptio Placentae | 1 | 2009 | 118 | 0.080 |
Why?
|
Diabetes Mellitus, Type 2 | 1 | 2012 | 11729 | 0.080 |
Why?
|
Humans | 31 | 2023 | 743811 | 0.080 |
Why?
|
Hedgehog Proteins | 1 | 2012 | 784 | 0.080 |
Why?
|
Placenta Previa | 1 | 2009 | 117 | 0.080 |
Why?
|
Fagopyrum | 1 | 2006 | 1 | 0.070 |
Why?
|
Protons | 1 | 2013 | 1129 | 0.070 |
Why?
|
Pregnancy | 6 | 2011 | 29140 | 0.070 |
Why?
|
DNA-Binding Proteins | 3 | 2013 | 9648 | 0.070 |
Why?
|
Isocitrate Dehydrogenase | 1 | 2012 | 871 | 0.070 |
Why?
|
Genes, Tumor Suppressor | 1 | 2011 | 1097 | 0.070 |
Why?
|
Chromosome Deletion | 1 | 2011 | 1396 | 0.070 |
Why?
|
Pulmonary Disease, Chronic Obstructive | 1 | 2021 | 3047 | 0.070 |
Why?
|
Cytomegalovirus Infections | 1 | 2013 | 820 | 0.070 |
Why?
|
Oligonucleotide Array Sequence Analysis | 2 | 2012 | 3917 | 0.070 |
Why?
|
Mice | 10 | 2023 | 81154 | 0.070 |
Why?
|
Breast Neoplasms | 1 | 2013 | 20827 | 0.070 |
Why?
|
Fetal Growth Retardation | 1 | 2010 | 566 | 0.070 |
Why?
|
Fertility | 1 | 2011 | 779 | 0.070 |
Why?
|
Female | 18 | 2021 | 380020 | 0.070 |
Why?
|
Placenta Accreta | 1 | 2009 | 225 | 0.070 |
Why?
|
Myelodysplastic Syndromes | 2 | 2013 | 1352 | 0.060 |
Why?
|
Antineoplastic Agents, Hormonal | 1 | 2013 | 1523 | 0.060 |
Why?
|
Kaplan-Meier Estimate | 2 | 2014 | 6539 | 0.060 |
Why?
|
Neoplasm Proteins | 2 | 2022 | 3706 | 0.060 |
Why?
|
Drug Resistance, Neoplasm | 2 | 2020 | 5170 | 0.060 |
Why?
|
Receptors, G-Protein-Coupled | 1 | 2012 | 1222 | 0.060 |
Why?
|
Gene Regulatory Networks | 1 | 2013 | 1707 | 0.060 |
Why?
|
Signal Transduction | 2 | 2022 | 23398 | 0.060 |
Why?
|
Repressor Proteins | 2 | 2012 | 3024 | 0.060 |
Why?
|
Transcription Factors | 4 | 2022 | 12209 | 0.060 |
Why?
|
Exons | 3 | 2014 | 2438 | 0.060 |
Why?
|
Disease Progression | 3 | 2017 | 13273 | 0.050 |
Why?
|
Intracellular Signaling Peptides and Proteins | 1 | 2012 | 2914 | 0.050 |
Why?
|
Cardiolipins | 1 | 2022 | 88 | 0.050 |
Why?
|
Polycythemia Vera | 2 | 2013 | 164 | 0.050 |
Why?
|
Cell Cycle Proteins | 1 | 2013 | 3463 | 0.050 |
Why?
|
Apoptosis | 2 | 2022 | 9718 | 0.050 |
Why?
|
Ultraviolet Rays | 1 | 2006 | 1060 | 0.050 |
Why?
|
Partial Pressure | 1 | 2021 | 254 | 0.050 |
Why?
|
Animals | 10 | 2023 | 168660 | 0.050 |
Why?
|
Cell Degranulation | 1 | 2022 | 287 | 0.050 |
Why?
|
Gases | 1 | 2021 | 197 | 0.050 |
Why?
|
Nucleotides | 1 | 2023 | 463 | 0.050 |
Why?
|
Oxidoreductases | 1 | 2023 | 424 | 0.050 |
Why?
|
Mice, Congenic | 1 | 2020 | 99 | 0.050 |
Why?
|
Cell Line, Tumor | 2 | 2013 | 16674 | 0.050 |
Why?
|
Gene Expression Profiling | 2 | 2015 | 9440 | 0.040 |
Why?
|
Histone Acetyltransferases | 1 | 2022 | 335 | 0.040 |
Why?
|
Prognosis | 3 | 2022 | 29052 | 0.040 |
Why?
|
Gene Library | 1 | 2022 | 1074 | 0.040 |
Why?
|
Leukemia, Myeloid | 2 | 2013 | 707 | 0.040 |
Why?
|
Nitriles | 2 | 2015 | 953 | 0.040 |
Why?
|
Practice Guidelines as Topic | 1 | 2016 | 7270 | 0.040 |
Why?
|
Candida albicans | 1 | 2022 | 394 | 0.040 |
Why?
|
Antioxidants | 1 | 2006 | 1658 | 0.040 |
Why?
|
Nerve Tissue Proteins | 1 | 2011 | 4463 | 0.040 |
Why?
|
Remission Induction | 2 | 2015 | 2384 | 0.040 |
Why?
|
Multivariate Analysis | 1 | 2012 | 12243 | 0.040 |
Why?
|
Cell Count | 1 | 2022 | 1855 | 0.040 |
Why?
|
Transgenes | 1 | 2022 | 1008 | 0.040 |
Why?
|
DNA | 1 | 2012 | 7295 | 0.040 |
Why?
|
Pyrimidines | 3 | 2015 | 2945 | 0.040 |
Why?
|
Animals, Genetically Modified | 1 | 2022 | 1552 | 0.040 |
Why?
|
Nuclear Proteins | 3 | 2022 | 5854 | 0.040 |
Why?
|
Antineoplastic Agents | 2 | 2020 | 13691 | 0.040 |
Why?
|
Cell Proliferation | 1 | 2012 | 10477 | 0.040 |
Why?
|
Base Sequence | 2 | 2022 | 12798 | 0.030 |
Why?
|
Phagocytosis | 1 | 2022 | 1539 | 0.030 |
Why?
|
Mice, Nude | 2 | 2013 | 3680 | 0.030 |
Why?
|
Glucose-6-Phosphate Isomerase | 1 | 2015 | 52 | 0.030 |
Why?
|
Benzeneacetamides | 1 | 2015 | 39 | 0.030 |
Why?
|
Mice, Inbred NOD | 1 | 2020 | 1876 | 0.030 |
Why?
|
Pyrans | 1 | 2015 | 54 | 0.030 |
Why?
|
Adult | 7 | 2017 | 213889 | 0.030 |
Why?
|
Sequence Analysis, RNA | 1 | 2022 | 2009 | 0.030 |
Why?
|
Polymerase Chain Reaction | 2 | 2013 | 6170 | 0.030 |
Why?
|
Heterocyclic Compounds, 3-Ring | 1 | 2015 | 215 | 0.030 |
Why?
|
Aged | 6 | 2021 | 163178 | 0.030 |
Why?
|
Vincristine | 1 | 2015 | 1039 | 0.030 |
Why?
|
Thrombocytosis | 1 | 2013 | 81 | 0.030 |
Why?
|
Genome-Wide Association Study | 1 | 2012 | 12259 | 0.030 |
Why?
|
Veratrum Alkaloids | 1 | 2012 | 25 | 0.030 |
Why?
|
Sulfones | 1 | 2015 | 434 | 0.030 |
Why?
|
Electrons | 1 | 2014 | 268 | 0.030 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2012 | 15518 | 0.030 |
Why?
|
Ganciclovir | 1 | 2013 | 258 | 0.030 |
Why?
|
Enzyme Inhibitors | 1 | 2023 | 3794 | 0.030 |
Why?
|
Dacarbazine | 1 | 2015 | 566 | 0.030 |
Why?
|
Thermodynamics | 1 | 2014 | 595 | 0.030 |
Why?
|
Camptothecin | 1 | 2015 | 576 | 0.030 |
Why?
|
Pyridines | 2 | 2015 | 2827 | 0.030 |
Why?
|
Immunoblotting | 1 | 2015 | 1683 | 0.030 |
Why?
|
Janus Kinases | 1 | 2013 | 244 | 0.030 |
Why?
|
Codon | 1 | 2013 | 611 | 0.030 |
Why?
|
Granulocytes | 1 | 2013 | 548 | 0.030 |
Why?
|
Bone Marrow Diseases | 1 | 2013 | 231 | 0.030 |
Why?
|
Neoplasm Transplantation | 1 | 2015 | 2085 | 0.030 |
Why?
|
Wnt Proteins | 1 | 2015 | 721 | 0.020 |
Why?
|
Sequence Analysis, DNA | 2 | 2013 | 4803 | 0.020 |
Why?
|
Myeloid-Lymphoid Leukemia Protein | 1 | 2013 | 294 | 0.020 |
Why?
|
Cross-Sectional Studies | 1 | 2012 | 25032 | 0.020 |
Why?
|
Luciferases | 1 | 2012 | 733 | 0.020 |
Why?
|
Tumor Microenvironment | 1 | 2022 | 3583 | 0.020 |
Why?
|
beta Catenin | 1 | 2015 | 1060 | 0.020 |
Why?
|
Anxiety Disorders | 1 | 2021 | 2684 | 0.020 |
Why?
|
Medulloblastoma | 1 | 2015 | 683 | 0.020 |
Why?
|
Chromatin | 1 | 2022 | 2931 | 0.020 |
Why?
|
Triazoles | 1 | 2015 | 904 | 0.020 |
Why?
|
Immunity, Innate | 1 | 2022 | 2961 | 0.020 |
Why?
|
Fetal Monitoring | 1 | 2010 | 70 | 0.020 |
Why?
|
Oxygen | 1 | 2021 | 4189 | 0.020 |
Why?
|
Thrombosis | 2 | 2013 | 2968 | 0.020 |
Why?
|
Male | 7 | 2021 | 349776 | 0.020 |
Why?
|
Pyrazines | 1 | 2015 | 1230 | 0.020 |
Why?
|
Cisplatin | 1 | 2015 | 1662 | 0.020 |
Why?
|
Mice, Transgenic | 1 | 2022 | 9731 | 0.020 |
Why?
|
Histone-Lysine N-Methyltransferase | 1 | 2013 | 671 | 0.020 |
Why?
|
Doxorubicin | 1 | 2015 | 2234 | 0.020 |
Why?
|
Middle Aged | 4 | 2021 | 213241 | 0.020 |
Why?
|
Random Allocation | 1 | 2013 | 2429 | 0.020 |
Why?
|
Genotype | 2 | 2014 | 12944 | 0.020 |
Why?
|
Oncogene Proteins | 1 | 2012 | 749 | 0.020 |
Why?
|
Gene Amplification | 1 | 2012 | 1063 | 0.020 |
Why?
|
Mice, Knockout | 1 | 2023 | 14563 | 0.020 |
Why?
|
Gene Rearrangement | 1 | 2013 | 1179 | 0.020 |
Why?
|
Ultrasonography, Doppler | 1 | 2010 | 458 | 0.020 |
Why?
|
Translocation, Genetic | 1 | 2013 | 1420 | 0.020 |
Why?
|
DNA, Plant | 1 | 2006 | 50 | 0.020 |
Why?
|
Anxiety | 1 | 2021 | 4288 | 0.020 |
Why?
|
Infant, Newborn | 3 | 2013 | 25609 | 0.020 |
Why?
|
Neoplasms | 1 | 2015 | 21675 | 0.020 |
Why?
|
Catalase | 1 | 2006 | 221 | 0.020 |
Why?
|
Plant Leaves | 1 | 2006 | 143 | 0.020 |
Why?
|
Regional Blood Flow | 1 | 2010 | 1525 | 0.020 |
Why?
|
Pedigree | 1 | 2014 | 4643 | 0.020 |
Why?
|
T-Lymphocytes | 1 | 2023 | 10179 | 0.020 |
Why?
|
Lipid Peroxidation | 1 | 2006 | 270 | 0.020 |
Why?
|
Xenograft Model Antitumor Assays | 1 | 2013 | 3547 | 0.020 |
Why?
|
Glycoproteins | 1 | 2013 | 2266 | 0.020 |
Why?
|
DNA Mutational Analysis | 1 | 2014 | 4183 | 0.020 |
Why?
|
Flow Cytometry | 1 | 2015 | 5973 | 0.020 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2012 | 4749 | 0.020 |
Why?
|
Blotting, Western | 1 | 2012 | 5179 | 0.020 |
Why?
|
Young Adult | 3 | 2017 | 56392 | 0.010 |
Why?
|
Superoxide Dismutase | 1 | 2006 | 595 | 0.010 |
Why?
|
Infant | 2 | 2017 | 35122 | 0.010 |
Why?
|
Peroxidase | 1 | 2006 | 611 | 0.010 |
Why?
|
Chromosome Mapping | 1 | 2011 | 4737 | 0.010 |
Why?
|
RNA, Small Interfering | 1 | 2012 | 3504 | 0.010 |
Why?
|
Disease Models, Animal | 1 | 2022 | 18027 | 0.010 |
Why?
|
Child, Preschool | 2 | 2017 | 40964 | 0.010 |
Why?
|
Antigens, CD | 1 | 2013 | 4026 | 0.010 |
Why?
|
Alleles | 1 | 2013 | 6934 | 0.010 |
Why?
|
Adolescent | 3 | 2017 | 85729 | 0.010 |
Why?
|
Mice, Inbred C57BL | 1 | 2020 | 21824 | 0.010 |
Why?
|
Immunohistochemistry | 1 | 2015 | 11360 | 0.010 |
Why?
|
Drug Delivery Systems | 1 | 2013 | 2217 | 0.010 |
Why?
|
Acute Disease | 1 | 2011 | 7150 | 0.010 |
Why?
|
Peptides | 1 | 2013 | 4406 | 0.010 |
Why?
|
Antiviral Agents | 1 | 2013 | 2984 | 0.010 |
Why?
|
Glioma | 1 | 2015 | 3401 | 0.010 |
Why?
|
Quality of Life | 1 | 2021 | 12788 | 0.010 |
Why?
|
Molecular Sequence Data | 1 | 2012 | 18107 | 0.010 |
Why?
|
Proportional Hazards Models | 1 | 2013 | 12354 | 0.010 |
Why?
|
Cell Line | 1 | 2013 | 15993 | 0.010 |
Why?
|
Carrier Proteins | 1 | 2011 | 5021 | 0.010 |
Why?
|
Chronic Disease | 1 | 2013 | 9139 | 0.010 |
Why?
|
Child | 2 | 2017 | 77637 | 0.010 |
Why?
|
RNA, Messenger | 1 | 2012 | 13028 | 0.010 |
Why?
|
Prospective Studies | 1 | 2021 | 53250 | 0.010 |
Why?
|
Prevalence | 1 | 2013 | 15211 | 0.010 |
Why?
|
Phenotype | 1 | 2014 | 16361 | 0.010 |
Why?
|
Colorectal Neoplasms | 1 | 2015 | 6773 | 0.010 |
Why?
|
Brain Neoplasms | 1 | 2015 | 8856 | 0.010 |
Why?
|
Kidney | 1 | 2010 | 7185 | 0.010 |
Why?
|
Genetic Predisposition to Disease | 1 | 2014 | 17439 | 0.010 |
Why?
|
Treatment Outcome | 1 | 2015 | 63042 | 0.010 |
Why?
|
Aged, 80 and over | 1 | 2013 | 57744 | 0.010 |
Why?
|